Sanofi (SNY) announced the acquisition of Dynavax (DVAX) for $15.50 per share, or $2.2 billion. This could be the last in a series of biotech M&A transactions this year, and it looks like a decent but ...
Core Scientific, Inc. investors face a looming crossroad as they're asked to vote on the upcoming acquisition by CoreWeave, Inc. later this month. CRWV has offered a premium bid that significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results